Sponsor:
Tisento Therapeutics
Code:
NCT06402123
Conditions
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
zagociguat 15mg
zagociguat 30mg
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-10. This information was provided to ClinicalTrials.gov by Tisento Therapeutics on 2025-10-22.